Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025)

Organogenesis Holdings has reported Construction in Progress over the past 3 years, most recently at $26.7 million for Q4 2025.

  • For Q4 2025, Construction in Progress rose 22.19% year-over-year to $26.7 million; the TTM value through Dec 2025 reached $26.7 million, up 22.19%, while the annual FY2025 figure was $26.7 million, 22.19% up from the prior year.
  • Construction in Progress for Q4 2025 was $26.7 million at Organogenesis Holdings, down from $27.5 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $59.1 million in Q4 2023 and troughed at $20.6 million in Q3 2024.
  • A 3-year average of $29.1 million and a median of $23.9 million in 2025 define the central range for Construction in Progress.
  • Biggest five-year swings in Construction in Progress: crashed 62.95% in 2024 and later skyrocketed 33.66% in 2025.
  • Year by year, Construction in Progress stood at $59.1 million in 2023, then crashed by 62.95% to $21.9 million in 2024, then grew by 22.19% to $26.7 million in 2025.
  • Business Quant data shows Construction in Progress for ORGO at $26.7 million in Q4 2025, $27.5 million in Q3 2025, and $23.9 million in Q2 2025.